{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:15:29Z","timestamp":1792451729086,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.biocel.2005.05.008","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T07:25:42Z","timestamp":1118733942000},"page":"2310-2320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Martina","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Alfalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Y.","family":"Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2005.05.008_bib1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(95)91688-1","article-title":"Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype","volume":"346","author":"Abrahamov","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2005.05.008_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0003-2697(86)90043-6","article-title":"A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies","volume":"154","author":"Aerts","year":"1986","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib3","doi-asserted-by":"crossref","unstructured":"Beutler, E., Sorge, J., Zimran, A., West, C., Kuhl, W., Westwood, B., et al. (1988). The molecular biology of Gaucher disease. In Lipid storage disorders. Biological and biomedical aspects (pp. 19\u201327). New York: Plenum Press.","DOI":"10.1007\/978-1-4613-1029-7_2"},{"key":"10.1016\/j.biocel.2005.05.008_bib4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2005.05.008_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Reports"},{"issue":"4","key":"10.1016\/j.biocel.2005.05.008_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0955-0674(00)00233-7","article-title":"ER quality control: Towards an understanding at the molecular level","volume":"13","author":"Ellgaard","year":"2001","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.biocel.2005.05.008_bib7","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1073\/pnas.82.20.7101","article-title":"Gene mapping and leader polypeptide sequence of human glucocerbraosidase: Implications for Gaucher disease","volume":"82","author":"Ginns","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2005.05.008_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0009-8981(83)90097-9","article-title":"Determination of Gaucher's disease phenotypes with monoclonal antibody","volume":"131","author":"Ginns","year":"1983","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.biocel.2005.05.008_bib9","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1172\/JCI119437","article-title":"Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients","volume":"99","author":"Grace","year":"1997","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2005.05.008_bib10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0021-9258(17)42166-1","article-title":"Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression","volume":"269","author":"Grace","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/clin.1993.1042","article-title":"Cell surface expression of lysosome-associated membrane proteins (LAMPs) in scleroderma: Relationship of lamp2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels","volume":"67","author":"Holcombe","year":"1993","journal-title":"Clinical Immunology and Immunopathology"},{"key":"10.1016\/j.biocel.2005.05.008_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/humu.1380030102","article-title":"Mutations causing Gaucher disease","volume":"3","author":"Horowitz","year":"1994","journal-title":"Human Mutation"},{"key":"10.1016\/j.biocel.2005.05.008_bib13","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1074\/jbc.M111500200","article-title":"The prosequence of human lactase-phlorizin hydrolase modulates the folding of the mature enzyme","volume":"277","author":"Jacob","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1432-1033.1987.tb11008.x","article-title":"Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts","volume":"164","author":"Jonsson","year":"1987","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib15","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-Octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: A potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.biocel.2005.05.008_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1360","article-title":"Differential expression of mucins 1-6 in papillary thyroid carcinoma: Evidence for transformation-dependent post-translational modifications of MUC1 in situ","volume":"200","author":"Magro","year":"2003","journal-title":"Journal of Pathology"},{"key":"10.1016\/j.biocel.2005.05.008_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02436006","article-title":"Characterization of glucocerebrosidase in Greek Gaucher disease patients: Mutation analysis and biochemical studies","volume":"18","author":"Michelakakis","year":"1995","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.biocel.2005.05.008_bib19","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1016\/S0021-9258(18)98898-8","article-title":"Expression of a full-length cDNA coding for human intestinal lactase-phlorizin hydrolase reveals an uncleaved, enzymatically active, and transport-competent protein","volume":"266","author":"Naim","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib20","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0021-9258(19)67845-2","article-title":"Characterization of human glucocerebrosidase from different mutant alleles","volume":"266","author":"Ohashi","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib21","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1021\/bi980785+","article-title":"Intrinsic fluorescence and conformational changes induced by phospholipids and saposin C","volume":"37","author":"Qi","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib22","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1074\/jbc.273.13.7189","article-title":"Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro","volume":"273","author":"Sato","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Letters"},{"key":"10.1016\/j.biocel.2005.05.008_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/humu.1380030105","article-title":"DNA mutational analysis of type 1 and type 3 Gaucher patients: How well do mutations predict phenotype?","volume":"3","author":"Sidransky","year":"1994","journal-title":"Human Mutation"},{"key":"10.1016\/j.biocel.2005.05.008_bib25","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation","volume":"278","author":"Sun","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib26","doi-asserted-by":"crossref","first-page":"25710","DOI":"10.1016\/S0021-9258(18)47306-1","article-title":"Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins","volume":"269","author":"Ward","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib27","doi-asserted-by":"crossref","first-page":"31946","DOI":"10.1074\/jbc.M003559200","article-title":"Cell type-dependent differences in thyroid peroxidase cell surface expression","volume":"275","author":"Zhang","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.05.008_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"Journal of Pathology"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272505001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272505001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:19:20Z","timestamp":1761200360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272505001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1357272505001597"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2005.05.008","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2005.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}